Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA

  • FDA Approval
  • March 28, 2024, 04:12 UTC
  • 35
  • 0 comments

FDA approve MOMETASONE FUROATE

Comment Full text

LUPIN

  • FDA Approval
  • March 28, 2024, 04:12 UTC
  • 42
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • March 28, 2024, 04:12 UTC
  • 38
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

TARO PHARMS

  • FDA Approval
  • March 27, 2024, 12:13 UTC
  • 47
  • 0 comments

FDA approve ACYCLOVIR

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • March 27, 2024, 11:46 UTC
  • 37
  • 0 comments

FDA approve LETERMOVIR

Comment Full text

NOVARTIS

  • FDA Approval
  • March 27, 2024, 11:46 UTC
  • 38
  • 0 comments

FDA approve IPTACOPAN HYDROCHLORIDE

Comment Full text

AMNEAL

  • FDA Approval
  • March 27, 2024, 09:17 UTC
  • 37
  • 0 comments

FDA approve FOSFOMYCIN TROMETHAMINE

Comment Full text

AMNEAL

  • FDA Approval
  • March 27, 2024, 09:17 UTC
  • 28
  • 0 comments

FDA approve ATAZANAVIR SULFATE

Comment Full text

AMNEAL

  • FDA Approval
  • March 27, 2024, 09:17 UTC
  • 33
  • 0 comments

FDA approve CIPROFLOXACIN; DEXAMETHASONE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • March 27, 2024, 09:17 UTC
  • 33
  • 0 comments

FDA approve CEFTRIAXONE SODIUM

Comment Full text
  • Previous
  • 491
  • 492
  • 493
  • 494
  • 495
  • Next

Search

News categories

  • Technical Exchange News(11746)
  • Event(4190)
  • SEC News(233974)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(142999)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin